These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10493567)

  • 1. Cellulose triacetate: another membrane for continuous renal replacement therapy.
    Ronco C; Brendolan A; Everard P; Irone M; Ballestri M; Cappelli G; Inguaggiato P; Bellomo R
    J Nephrol; 1999; 12(4):241-7. PubMed ID: 10493567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure.
    Pichaiwong W; Leelahavanichkul A; Eiam-ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S65-72. PubMed ID: 17044456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous renal replacement therapy: evolution in technology and current nomenclature.
    Ronco C; Bellomo R
    Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal replacement therapies for critically ill pediatric patients.
    Sakarcan A; Karaböcüoğlu M
    Turk J Pediatr; 1995; 37(1):7-13. PubMed ID: 7732612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achievements and new directions in continuous renal replacement therapies.
    Ronco C; Barbacini S; Digito A; Zoccali G
    New Horiz; 1995 Nov; 3(4):708-16. PubMed ID: 8574601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.
    Agha-Razii M; Amyot SL; Pichette V; Cardinal J; Ouimet D; Leblanc M
    Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients.
    Ronco C
    Clin Nephrol; 1993 Oct; 40(4):187-98. PubMed ID: 8261674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous veno-venous renal replacement therapies in critically ill neonates and children].
    López-Herce Cid J; Carrillo Alvarez A; Panadero Carlavilla E; Sánchez Sánchez C; Moral Torrero R; Bustinza Arriourtúa A
    An Esp Pediatr; 1998 Jul; 49(1):39-45. PubMed ID: 9718765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History and development of continuous renal replacement techniques.
    Burchardi H
    Kidney Int Suppl; 1998 May; 66():S120-4. PubMed ID: 9573587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy.
    Floris M; Marchionna N; Clementi A; Kim JC; Cruz DN; Nalesso F; Zanella M; Garzotto F; de Cal M; Virzì GM; Brendolan A; Ronco C
    Blood Purif; 2011; 32(2):133-8. PubMed ID: 21654165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes.
    Khajehdehi P; Jamal JA; Bastani B
    Clin Nephrol; 2000 Oct; 54(4):351-5. PubMed ID: 11076113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of 17 cytokines, HMGB1, and albumin by continuous hemofiltration using a cellulose triacetate membrane: an ex vivo study.
    Yasuda N; Goto K; Yamamoto S; Hidaka S; Hagiwara S; Noguchi T
    J Surg Res; 2012 Jul; 176(1):226-31. PubMed ID: 22099603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of continuous extracorporeal replacement of renal function].
    Opatrný K
    Vnitr Lek; 1996 Dec; 42(12):818-24. PubMed ID: 9072880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL
    Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration.
    Liu S; Shi W; Liang X; Su Y; Liang Y; Zhang B; Ye Z; Xu L; Xia Y; He C; Ma J; Tao Y; Ye H; Li H
    Blood Purif; 2010; 29(4):375-82. PubMed ID: 20484898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous arteriovenous hemodialysis with cuprophan membrane].
    Cotera A; Lorca E; Saffie A
    Rev Med Chil; 1991 Aug; 119(8):939-40. PubMed ID: 1844779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.